Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Switch Symbol:
Net Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
13.39%
↑ 172% above average
Average (9y)
-18.69%
Historical baseline
Range
High:171.44%
Low:-159.50%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 13.39% |
| 2023 | 18.22% |
| 2022 | 38.93% |
| 2021 | -108.33% |
| 2020 | -76.35% |
| 2019 | 74.54% |
| 2018 | -130.23% |
| 2017 | -159.50% |
| 2016 | 171.44% |
| 2015 | -29.05% |